Viking Therapeutics ($VKTX) is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders. It
Healthcare can be a difficult sector to traverse, fraught with competition and often involving uncertain technologies that require lengthy periods of R&D with little to no guarantee of
June 20 saw one of the biggest sell-offs in recent history on the heels of the Fed’s concerns. So we decided to look at the 10 investments that fared the best in a rough climate. We found five
Ligand Pharmaceuticals (LGND) has signed global license and supply agreements with Spectrum Pharmaceuticals (SPPI) to develop and commercialize Ligand’s Catisol-enabled, propylene glycol-free
